 |
| Download this
document in PDF format.
PDF reading software can be found here. |
Nitrogen Oxides in Exhaled Breath Condensate
Multiple nitrogen oxides (NOx) have been reported in EBC.
Nitrogen oxides in EBC are likely derived from two compartments
of the exhaled air:
- aerosolized particles of airway lining fluid (which contains
many nitrogen oxides)
- Gas phase nitric oxide, which then is oxidized in the EBC
to higher oxides of Nitrogen.
The relative contributions of these sources of NOx in EBC
have not been clarified, and conceivably vary in certain diseases.
Nitrite (NO2-)
Advantages
- Relatively easy to measure.
- Recognizable value given its chemical relationships with
nitric oxide
- Multiple studies report its presence in EBC
- Complementary to exhaled NO and other NOx assays.
Disadvantages
- Anatomic source not elucidated, but risk of upper airway
contamination is present
- Not amenable to long storage. Nitrite is a reactive molecule.
It is not stable at low pH and can readily be converted to
nitric oxide, which then can evolve out of EBC as a gas.
Alternatively, in EBC can be oxidized to NO3- or can be consumed
by reaction with reduced thiols (to form SNOs) or tyrosine
residues (to form nitrotyrosine).
- Laboratory contamination is ubiquitous. Nitrite can be
found on almost all surfaces, including the insides of microcentrifuge
tubes (which are commonly used to store EBC), pipette tips,
etc. Many materials may leech out NO (and therefore the higher
oxides). This occurs, for example, in Mylar bags used for
off-line exhaled NO assay. Large nitrite contamination is
present on the surface of latex gloves (irregardless of sterility,
of course). Low extracable ion gloves are available that
have minimal surface contamination. Please contact us for
information on how to obtain these gloves.
Expected levels
- In health EBC NO2- levels are approximately 0.5 - 1 micromolar(1,
2)
- In disease, levels 2-3 fold higher are commonly reported.
Much higher levels have also been reported occasionally.
Assays
- Greiss Reaction
- available as kits through many lab supply companies-however
the reagents can be readily made in a research lab for
approximately 1/100th of the cost of the kits).
- limit of detection is approximately 0.5 micromolar(1)
- Chemiluminescence
- after reduction in potassium iodide/acetic acid, nitrite
will evolve as NO which can be analyzed in a nitric oxide
analyzer. The Sievers NOA is perhaps the most used for
aqueous phase NOx assays. Level of detection 0.1 micromolar
(with 20 ?L sample). Can be improved substantially if more
EBC sample is used.
- Several other colorimetric assays are available, but generally
with higher detection limits.
Recommendations
- Rinse with deionized water everything that will contact
your EBC sample, and do so as soon as possible before use.
Be meticulous about this. Trust nothing to be nitrite-free.
- Be circumspect about the Griess assay, as you will be working
near its detection limit.
- Minimize storage time. Assay as soon as possible after
collection, especially if dealing with illnesses in which
EBC pH is often low (CF, asthma, COPD, and others)
- It is unclear what the plural term "nitrites" indicates
when dealing with aqueous solutions. Nitrites are salts,
and this is a reasonable term for solid phase. But in aqueous
phase, the preferred is the singular, "nitrite."
NITRATE (NO3-)
Advantages
- Relatively easy to measure.
- Recognizable value given its chemical relationships with
nitric oxide
- Multiple studies report its presence in EBC
- Stable. Can be stored indefinitely. (conceivably rises
slightly in storage as lower oxides of Nitrogen slowly oxidize.)
- Complementary to exhaled NO and other NOx assays.
Disadvantages
- Anatomic source not elucidated, but our unpublished data
reveal that the overwhelming amount of NO3- is derived from
the lower airway. There are a small number of patients in
whom the upper airway appears to be relevant to NO3-
- Laboratory contamination is ubiquitous. Nitrate can be
found on almost all surfaces, including the insides of microcentrifuge
tubes (which are commonly used to store EBC), pipette tips,
etc. Many materials may leech out NO (and therefore the higher
oxides). This occurs, for example, in Mylar bags used for
off-line exhaled NO assay. Large nitrate contamination is
present on the surface of latex gloves (irregardless of sterility,
of course). Low extracable ion gloves are available that
have minimal surface contamination. Please contact us for
more information regarding such gloves.
Assays
- Griess Reaction
- Modified by the addition of an initial step of enzymatic
nitrate reductase. This assay will identify NO3- as well
as NO2-. Necessary to perform both the basic Greiss and the
modified Greiss in order to quantitate NO3- and NO2- individually.
Level of detection approximately 1 ?M
- Chemiluminescence
- after reduction in vanadium chloride in hydrochloric acid
at 95?, nitrate (and nitrite) will evolve as NO which can
be analyzed in a nitric oxide analyzer. The Sievers NOA is
perhaps the most used for aqueous phase NOx assays. Level
of detection 0.1 micromolar (with 20 ?L sample). Can be improved
substantially if more EBC sample is used. Note that this
assay also will read all SNOs, and possibly nitrotyrosine
(the latter only to a small extent).
Recommendations
- Rinse with deionized water everything that will contact
your EBC sample, and do so as soon as possible before use.
Be meticulous about this. Trust nothing to be nitrate-free.
- The term NOx refers to all nitrogen oxides. Many nitrate
assays are actually identifying several oxides of nitrogen,
and this should be recognized.
- For best understanding of NOx in the lung, consider assaying
all the forms you can. Exhaled NO is but a very small part
of the NOx picture.
S-nitrosothiols
These compounds are endogenously formed small polypeptides
or full proteins with an NO+ group replacing a sulfhydryl H+
on a cysteine residue. The process of replacing the H+ with
NO+ is called nitrosation, or nitrosylation for proteins.
S-nitrosoglutathione (GSNO) is a nitrosylated tripeptide that
is an endogenous bronchodilator. GSNO is reported to be elevated
in the EBC of asthmatic patients, although it is low in the
tracheobronchial secretions of severe acutely ill asthmatics.
Assays are best performed by chemiluminescence. Detailed information
about S-nitroshiothiol assays are available from us. Simply
send an email or give us a call, and we will provide whatever
information that you may need.
Nitrotyrosine
Nitrotyrosine is formed by reaction of tyrosine residues with
peroxynitrite, acidic nitrite, or nitrogen dioxide. Carbon
dioxide presence accelerates the formation of nitrotyrosine.
The presence of this molecule is indicative of an oxidative
environment with nitrogen oxides available, and the term nitrative
stress has been coined on the reasonable assumption (and some
data) that nitration adversely affects protein function. Nitrotyrosine
has been reported to be identified in EBC.
Nitrotyrosine is assayed primarily by ELISA, kits for which
are available commercially. CAUTION: these are standard sandwich
ELISAs, and therefore cannot be measuring Nitrotyrosine as
a single amino acid, which is simply too small to be measured
in sandwich ELISA, but rather are assuredly identifying nitrated
proteins. This is not made clear in the labeling, but should
be kept in mind, especially as manuscripts are being prepared.
An additional caveat is that proteins that are nitrated only
at one site should not be identifiable with the currently available
commercial sandwich ELISA kits. Of course, with all immunoassays,
the specificity of the antibodies employed must always be considered,
and non-specific background controlled for.
Mass spectroscopic assays after protein digestion have been
developed, although there is minimal information published
to date.
References
- Hunt, J., and B. Gaston. 2000. Airway nitrogen oxide
measurements in asthma and other pediatric respiratory
diseases. J Pediatr 137(1):14-20.
- Hunt, J., R. E. Byrns, L. J. Ignarro, and B. Gaston.
1995. Condensed expirate nitrite as a home marker for acute
asthma [letter]. Lancet 346(8984):1235-6.
- Balint, B., S. A. Kharitonov, T. Hanazawa, L. E. Donnelly,
P. L. Shah, M. E. Hodson, and P. J. Barnes. 2001. Increased
nitrotyrosine in Exhaled Breath Condensate in cystic fibrosis. Eur
Respir J 17(6):1201-7.
- Balint, B., L. E. Donnelly, T. Hanazawa, S. A. Kharitonov,
and P. J. Barnes. 2001. Increased nitric oxide metabolites
in Exhaled Breath Condensate after exposure to tobacco
smoke. Thorax 56(6):456-61.
- Corradi, M., P. Montuschi, L. E. Donnelly, A. Pesci,
S. A. Kharitonov, and P. J. Barnes. 2001. Increased nitrosothiols
in Exhaled Breath Condensate in inflammatory airway diseases. Am
J Respir Crit Care Med 163(4):854-8.
- Corradi, M., A. Pesci, R. Casana, R. Alinovi, M. Goldoni,
M. Vittoria Vettori, and A. Cuomo. 2003. Nitrate in Exhaled
Breath Condensate of patients with different airway diseases. Nitric
Oxide 8(1):26-30.
- Csoma, Z., A. Bush, N. M. Wilson, L. Donnelly, B. Balint,
P. J. Barnes, and S. A. Kharitonov. 2003. Nitric oxide
metabolites are not reduced in Exhaled Breath Condensate
of patients with primary ciliary dyskinesia. Chest 124(2):633-8.
- Dziedzic, B., J. Mazanowska-Gajdowicz, A. Walczewska,
A. Sarniak, and D. Nowak. 2003. Comparison of cadmium and
enzyme-catalyzed nitrate reduction for determination of
NO(2)(-)/NO(3)(-) in breath condensate. Clin Chim Acta 335(1-2):65-74.
- Formanek, W., D. Inci, R. P. Lauener, J. H. Wildhaber,
U. Frey, and G. L. Hall. 2002. Elevated nitrite in breath
condensates of children with respiratory disease. Eur
Respir J 19(3):487-91.
- Ganas, K., S. Loukides, G. Papatheodorou, P. Panagou,
and N. Kalogeropoulos. 2001. Total nitrite/nitrate in expired
breath condensate of patients with asthma. Respir Med 95(8):649-54.
- Gessner, C., S. Hammerschmidt, H. Kuhn, T. Lange, L.
Engelmann, J. Schauer, and H. Wirtz. 2003. Exhaled Breath
Condensate nitrite and its relation to tidal volume in
acute lung injury. Chest 124(3):1046-52.
- Hanazawa, T., S. A. Kharitonov, and P. J. Barnes. 2000.
Increased nitrotyrosine in Exhaled Breath Condensate of
patients with asthma. Am J Respir Crit Care Med 162(4
Pt 1):1273-6.
- Ho, L. P., J. A. Innes, and A. P. Greening. 1998. Nitrite
levels in breath condensate of patients with cystic fibrosis
is elevated in contrast to exhaled nitric oxide. Thorax 53(8):680-4.
- Hunt, J. F., K. Fang, R. Malik, A. Snyder, N. Malhotra,
T. A. Platts-Mills, and B. Gaston. 2000. Endogenous airway
acidification. Implications for asthma pathophysiology. Am
J Respir Crit Care Med 161(3 Pt 1):694-9.
- Kostikas, K., G. Papatheodorou, K. Ganas, K. Psathakis,
P. Panagou, and S. Loukides. 2002. pH in Expired Breath
Condensate of Patients with Inflammatory Airway Diseases. Am
J Respir Crit Care Med 165(10):1364-70.
- Latzin, P., and M. Griese. 2002. Exhaled hydrogen peroxide,
nitrite and nitric oxide in healthy children: decrease
of hydrogen peroxide by atmospheric nitric oxide. European
Journal of Medical Research 7(8):353-8.
- Latzin, P., J. Beck, A. Bartenstein, and M. Griese. 2003.
Comparison of Exhaled Breath Condensate from nasal and
oral collection. Eur J Med Res 8(11):505-10.
|